United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50405-301_8d5b3de5-1dce-43e9-9858-c0439034f86a
- Product NDC
- 50405-301
- Form
- TABLET
- Composition / generic term
- Levetiracetam
- Labeler
- SOHM, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240527
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (50405-301-01) · 50405-301-01
- 120 TABLET in 1 BOTTLE (50405-301-02) · 50405-301-02
- 500 TABLET in 1 BOTTLE (50405-301-03) · 50405-301-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →